Michela Asperti

Brescia, 25123, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications

Current Landscape of Hepcidin Therapeutics.

Current Landscape of Hepcidin Therapeutics.

Journal: Advances in experimental medicine and biology
Published: July 02, 2025

Didox, a ribonucleotide reductase inhibitor with iron chelator properties, counteracts the in vitro and in vivo growth of rhabdomyosarcoma cells.

Didox, a ribonucleotide reductase inhibitor with iron chelator properties, counteracts the in vitro and in vivo growth of rhabdomyosarcoma cells.

Journal: Biochemical pharmacology
Published: June 15, 2025

Synthetic inhibition of SREBP2 and the mevalonate pathway blocks rhabdomyosarcoma tumor growth in vitro and in vivo and promotes chemosensitization.

Synthetic inhibition of SREBP2 and the mevalonate pathway blocks rhabdomyosarcoma tumor growth in vitro and in vivo and promotes chemosensitization.

Journal: Molecular metabolism
Published: September 26, 2024

Genetic iron overload aggravates, and pharmacological iron restriction improves, MDS pathophysiology in a preclinical study.

Genetic iron overload aggravates, and pharmacological iron restriction improves, MDS pathophysiology in a preclinical study.

Journal: Blood
Published: July 23, 2024

Improving CORM technology for the treatment of delayed hemolytic transfusion reaction.

Improving CORM technology for the treatment of delayed hemolytic transfusion reaction.

Journal: HemaSphere
Published: July 01, 2024

Sevuparin strongly reduces hepcidin expression in cells, mice, and healthy human volunteers.

Sevuparin strongly reduces hepcidin expression in cells, mice, and healthy human volunteers.

Journal: HemaSphere
Published: February 13, 2024

Statin-Sensitive Akt1/Src/Caveolin-1 Signaling Enhances Oxidative Stress Resistance in Rhabdomyosarcoma.

Statin-Sensitive Akt1/Src/Caveolin-1 Signaling Enhances Oxidative Stress Resistance in Rhabdomyosarcoma.

Journal: Cancers
Published: November 21, 2023

Flavor of Iron at EHA2023: Novel Regulatory Mechanisms and Therapeutic Options for the Correction of Anemia.

Flavor of Iron at EHA2023: Novel Regulatory Mechanisms and Therapeutic Options for the Correction of Anemia.

Journal: HemaSphere
Published: October 06, 2023

Iron supplementation enhances RSL3-induced ferroptosis to treat naïve and prevent castration-resistant prostate cancer.

Iron supplementation enhances RSL3-induced ferroptosis to treat naïve and prevent castration-resistant prostate cancer.

Journal: Cell death discovery
Published: January 18, 2023

The modulation of iron metabolism affects the Rhabdomyosarcoma tumor growth in vitro and in vivo.

The modulation of iron metabolism affects the Rhabdomyosarcoma tumor growth in vitro and in vivo.

Journal: Clinical and experimental medicine
Published: October 05, 2022

Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway Inhibitors.

Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway Inhibitors.

Journal: Cells
Published: August 08, 2022

Biochemical, Biophysical and Functional Characterization of an Insoluble Iron Containing Hepcidin-Ferritin Chimeric Monomer Assembled Together with Human Ferritin H/L Chains at Different Molar Ratios.

Biochemical, Biophysical and Functional Characterization of an Insoluble Iron Containing Hepcidin-Ferritin Chimeric Monomer Assembled Together with Human Ferritin H/L Chains at Different Molar Ratios.

Journal: Current issues in molecular biology
Published: November 15, 2021
Showing 1-12 of 35

Last Updated: 09/26/2026